Sciencast Management LP Novo Cure LTD Transaction History

Sciencast Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$56.6 - $89.9 $56,769 - $90,169	1,003 Added 31.88%	4,149 $278,000
Q1 2022 Apr 26, 2022	SELL	$60.15 - $84.52 $454,012 - $637,956	-7,548 Reduced 70.58%	3,146 $263,000
Q4 2021 Jan 20, 2022	BUY	$75.08 - $121.99 $622,638 - $1.01 Million	8,293 Added 345.4%	10,694 $802,000
Q3 2021 Oct 21, 2021	BUY	$116.17 - $194.55 $278,924 - $467,114	2,401 New	2,401 $265,000
Q2 2021 Jul 28, 2021	SELL	$130.4 - $225.58 $1.12 Million - $1.93 Million	-8,575 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$124.11 - $190.17 $1.06 Million - $1.63 Million	8,575 New	8,575 $1.14 Million
Q4 2020 Feb 04, 2021	SELL	$112.16 - $174.14 $521,544 - $809,750	-4,650 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$58.05 - $111.31 $316,372 - $606,639	-5,450 Reduced 53.96%	4,650 $622,000
Q2 2020 Jul 29, 2020	BUY	$57.2 - $74.41 $577,720 - $751,541	10,100 New	10,100 $582,000
Q1 2020 Apr 17, 2020	SELL	$57.05 - $95.75 $428,844 - $719,752	-7,517 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$68.3 - $93.8 $513,411 - $705,094	7,517 New	7,517 $633,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Sciencast Management LP, based on Form 13F filings with the SEC.

Stay updated on Sciencast Management LP with notifications on news.